Abstract:Background: Although a larger number of antiepileptic drugs became available in the last decades, epilepsy remains drug-resistant in approximately a third of patients. Ketogenic diet (KD), first proposed at the beginning of the last century, is complex and has anticonvulsant effects, yet not completely understood. Over the last decades, different types of ketogenic diets (KDs) have been developed, namely classical KD and modified Atkins diet (MAD). They offer an effective alternative for children and adults with drug-resistant epilepsies. Methods: We review several papers on KDs as an adjunctive treatment of refractory epilepsy of children and adults, discussing its efficacy and adverse events. Because of the heterogenous, uncontrolled nature of the studies, we analyzed all studies individually, without a meta-analysis. Results: KDs may be considered first choice treatment in some specific metabolic conditions, such as glucosetransporter type 1 and pyruvate dehydrogenase deficiencies, and mitochondrial complex I defects. Preliminary findings indicate that KDs may be specifically effective in some epileptic syndromes, such as West syndrome, severe myoclonic epilepsy of infancy, myoclonic-astatic epilepsy, febrile infection related epileptic syndrome, and drug-resistant idiopathic generalized epilepsies or refractory status epilepticus. Short term adverse events are usually mild in both children and adults, including gastrointestinal symptoms, hyperlipidemia, and hypercalciuria; potential long term adverse effects include nephrolitiasis, decreased bone density, and liver steatosis. Possible atherosclerotic effects remain a concern. Patients on KDs should be carefully monitored in specialized centers during initiation, maintenance and withdrawal periods, in order to minimize such adverse events, and to improve compliance. Although the majority of KD trials on children and adults with drug-resistant epilepsies are openlabel, uncontrolled studies based on small samples, an increasing number of randomized controlled trials have provided better quality evidence on its efficacy in recent years. Conclusion: There is a need for future randomized clinical trials aimed to confirm the efficacy of KDs in specific epileptic syndromes, and to provide further information about some practical unsolved problems, i.e. for how long KD treatment should be continued.

The ketogenic diet in patients with myoclonic status in non-progressive encephalopathy

Ketogenic diet in patients with myoclonic-astatic epilepsy

Ketogenic diet in patients with Lennox-Gastaut syndrome

Ketogenic diet in patients with Dravet syndrome

Efficacy of a ketogenic diet in resistant myoclono-astatic epilepsy: A French multicenter retrospective study

Ketogenic diet in patients with epileptic encephalopathy with electrical status epilepticus during slow sleep

Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus

Ketogenic Diet in patients with refractory epilepsy

Prospective study of the efficacy of a ketogenic diet in 20 patients with Dravet syndrome

The MCT-ketogenic diet as a treatment option in refractory childhood epilepsy: A prospective study with 2-year follow-up

Impressive efficacy of the ketogenic diet in a KCNQ2 encephalopathy infant: a case report and exhaustive literature review

Ketogenic diet use in children with intractable epilepsy secondary to malformations of cortical development: A two- centre experience

Efficacy and Safety of the Ketogenic Diet for Mitochondrial Disease With Epilepsy: A Prospective, Open-labeled, Controlled Study

A Prospective Study on Changes in Nutritional Status and Growth Following Two Years of Ketogenic Diet (KD) Therapy in Children with Refractory Epilepsy

Therapeutic Effects of the Ketogenic Diet in Children with Lennox-Gastaut Syndrome

Therapeutic Success of the Ketogenic Diet As A Treatment Option for Epilepsy: A Meta-Analysis

The Efficacy of Ketogenic Diet in 60 Chinese Patients with Dravet Syndrome

Prospective Study on Ketogenic Diet on Refractory Epilepsy in Children

Ketogenic Diets in the Treatment of Epilepsy

Safety and Effectiveness of the Prolonged Treatment of Children with a Ketogenic Diet

Evaluating the efficacy of a ketogenic diet in managing drug resistant paediatric DEDPC5-related epilepsy